Hanmi Cap, For Your Successful mRNA Research

In an interview at the TIDES USA conference in San Diego, Calif., Sung Jun Park, Project Manager, Global Business, at Hanmi Fine Chemical, discusses the company’s role as a leading CDMO company in South Korea and its expertise in manufacturing active pharmaceutical ingredients. Park highlights Hanmi’s recent expansion into mRNA raw materials and the company’s primary product, Hanmi Cap, a novel cap analog structure used in the in vitro transcription of mRNA. Additionally, Park shares recent developments in cap candidates for self-amplifying RNAs.